IRIS
RUSSO, CINZIA VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.194
EU - Europa 680
AS - Asia 226
AF - Africa 32
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.177
IT - Italia 330
CN - Cina 136
NL - Olanda 114
DE - Germania 51
IR - Iran 43
UA - Ucraina 42
IE - Irlanda 41
FI - Finlandia 32
CI - Costa d'Avorio 29
IN - India 27
GB - Regno Unito 23
FR - Francia 17
CA - Canada 16
VN - Vietnam 12
SE - Svezia 8
BG - Bulgaria 6
ES - Italia 4
BR - Brasile 3
ZA - Sudafrica 3
BE - Belgio 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
SG - Singapore 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
JP - Giappone 1
MK - Macedonia 1
MT - Malta 1
PT - Portogallo 1
QA - Qatar 1
Totale 2.136
Salva come PNG Salva come JPEG
Città #
Chandler 277
Amsterdam 111
Ashburn 99
Millbury 64
Napoli 52
Beijing 46
Nanjing 45
Naples 45
Des Moines 43
Princeton 40
Boston 27
Lawrence 23
Norwalk 22
Wilmington 20
Rome 18
Pune 13
San Jose 13
Cava De' Tirreni 12
Dong Ket 12
Seattle 11
Ottawa 10
Houston 9
Nanchang 9
Redwood City 8
Jacksonville 7
Shenyang 7
Tianjin 7
Kronberg 6
Los Angeles 6
Milan 6
Sofia 6
Dearborn 5
Fairfield 5
Hebei 5
Jiaxing 5
Mountain View 5
Washington 5
Augusta 4
New York 4
Paris 4
Brusciano 3
Buffalo 3
Changsha 3
Dublin 3
Duque de Caxias 3
Forino 3
Grand Rapids 3
Gricignano di Aversa 3
Menlo Park 3
Muizenberg 3
San Mateo 3
Toronto 3
Vermezzo 3
Acerra 2
Aversa 2
Benidorm 2
Boardman 2
Castellammare Di Stabia 2
Changchun 2
Chengdu 2
Darmstadt 2
Frankfurt am Main 2
Gragnano 2
Hong Kong 2
Indiana 2
Lappeenranta 2
Las Vegas 2
London 2
Marsala 2
Marsico Nuovo 2
Nuremberg 2
Pomezia 2
Presov 2
Saarbrücken 2
Saint Louis 2
Sant'arpino 2
Torre Annunziata 2
Waanrode 2
Woodbridge 2
Albenga 1
Albuquerque 1
Ankara 1
Ardabil 1
Atlanta 1
Bari 1
Beaverton 1
Belize City 1
Bellona 1
Bengaluru 1
Bitonto 1
Borås 1
Burano 1
Burlington 1
Böblingen 1
Cambridge 1
Caserta 1
Cava 1
Centrale 1
Chicago 1
Cicciano 1
Totale 1.228
Salva come PNG Salva come JPEG
Nome #
Quality of Life and Cognitive function in pediatric and young adults multiple sclerosis: a cross-sectional study 124
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study 71
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 65
Modifications of resting state networks in spinocerebellar ataxia type 2 58
Quality of life and cognitive function in pediatric and young multiple sclerosis patients: a cross-sectional study 57
Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine 53
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 51
Cognitive decline in Huntington's disease expansion gene carriers 50
A 8-year retrospective cohort study comparing Interferon-beta formulations for relapsing-remitting multiple sclerosis 49
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 48
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 47
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 47
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 46
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 45
Prevalence and features of non-motor symptoms in Wilson's disease 44
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 43
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 42
Uric acid: a potential biomarker of multiple sclerosis and of its disability 41
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 40
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 40
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis 40
A randomized clinical trial of lithium in multiple system atrophy. 39
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 39
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 39
Suicidal ideation in a European Huntington's disease population. 37
A longitudinal real-life comparison study of natalizumab and fingolimod 37
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis 36
Mobitz type I and II atrioventricular blocks during fingolimod therapy 36
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis 36
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 34
Clinical manifestations of intermediate allele carriers in Huntington disease 34
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 33
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 32
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 32
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 31
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 30
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 30
The Framingham cardiovascular risk score in multiple sclerosis 30
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 30
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 29
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015 29
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 29
Cerebellar lobule atrophy and disability in progressive MS 29
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 28
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 27
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 27
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 27
Cardiovascular profile improvement during Natalizumab treatment 24
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 24
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 22
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 22
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 21
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 21
A Novel PSEN1 Mutation in a Patient with Sporadic Early-Onset Alzheimer's Disease and Prominent Cerebellar Ataxia. 20
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis 20
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 19
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study 19
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis 16
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis 15
Pulse pressure and presence of coronary artery calcification 15
Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants 13
Multiple cranial neuropathy due to varicella zoster virus reactivation without vesicular rash: a challenging diagnosis 13
Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin 13
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 11
A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine 11
Pregnancy outcomes in alemtuzumab treated women with multiple sclerosis: a case series 10
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study 10
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 9
A real-world study of alemtuzumab in a cohort of Italian patients 8
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 8
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series 8
Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations 7
Recurrent reflex syncope in idiopathic intracranial hypertension patient resolved after lumbar puncture: pathogenetic implications 6
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study 5
The putative role of trigemino-vascular system in brain perfusion homeostasis and the significance of the migraine attack 5
Clinical manifestations of intermediate allele carriers in Huntington disease 2
Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study 2
β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease 2
Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease 1
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 1
Totale 2.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 3 9 2
2019/2020275 76 27 17 17 6 15 18 14 3 45 33 4
2020/2021187 21 10 6 25 11 14 17 7 15 16 28 17
2021/2022423 5 3 9 4 11 24 8 21 55 37 99 147
2022/2023700 67 66 19 35 77 80 21 63 102 116 37 17
2023/2024386 25 73 45 32 28 51 49 66 7 10 0 0
Totale 2.344